Equities

Muromachi Chemicals Inc

4885:TYO

Muromachi Chemicals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)737.00
  • Today's Change-7.00 / -0.94%
  • Shares traded6.90k
  • 1 Year change-8.79%
  • Beta1.0510
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of May 31 2024202420232022
ASSETS
Cash And Short Term Investments1,050853865
Total Receivables, Net1,4531,6871,704
Total Inventory895976879
Prepaid expenses472131
Other current assets, total364515
Total current assets3,4813,5823,495
Property, plant & equipment, net1,060912908
Goodwill, net------
Intangibles, net657040
Long term investments27710144
Note receivable - long term------
Other long term assets396659
Total assets5,0594,9484,798
LIABILITIES
Accounts payable519824838
Accrued expenses328295285
Notes payable/short-term debt10.00500700
Current portion long-term debt/capital leases325197203
Other current liabilities, total411239200
Total current liabilities1,5932,0562,225
Total long term debt1,103873785
Total debt1,4381,5701,688
Deferred income tax------
Minority interest------
Other liabilities, total92105107
Total liabilities2,7883,0333,117
SHAREHOLDERS EQUITY
Common stock143143143
Additional paid-in capital670666686
Retained earnings (accumulated deficit)1,3931,137952
Treasury stock - common(36)(50)(110)
Unrealized gain (loss)101189.66
Other equity, total0.000.220.00
Total equity2,2711,9151,681
Total liabilities & shareholders' equity5,0594,9484,798
Total common shares outstanding3.983.933.73
Treasury shares - common primary issue0.120.170.36
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.